Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Sophie Vanherrewege
Observed name:
Vanherrewege, Sophie
Institution:
Ghent University Hospital
Observed institution:
Ghent University Hospital
ORCID:
0000-0002-0942-1106
Observed ORCID:
0000-0002-0942-1106
OpenAlex ID:
A5079640824
Efficacy and safety of camostat mesylate in early COVID-19 disease in an ambulatory setting: a randomized placebo-controlled phase II trial
2022
·
Els Tobback
, Sophie Degroote
, et al.
·
International Journal of Infectious Diseases
·
33
PDF
In-depth Analysis of the HIV Reservoir Confirms Effectiveness and Safety of Dolutegravir/Lamivudine in a Phase 4 Randomized Controlled Switch Trial (RUMBA)
2024
·
Marie-Angélique De Scheerder
, Sophie Degroote
, et al.
·
The Journal of Infectious Diseases
·
14
PDF
Staging of immuno-virological dynamics during acute HIV infection in a Belgian prospective cohort study
2024
·
Jozefien De Clercq
, Marie-Angélique De Scheerder
, et al.
·
Journal of Virus Eradication
·
3
Show more works
View as search
Works count:
5
Citation count:
54
H-index:
3
I10-index:
2
Year
Topic
Type